Catch-22 concentrates institutional research investments
This catch-22 guarantees that our investments in institutions will be concentrated
May Senate hearing
J
Jay BhattacharyaNational Institutes of Health · Director
More from Jay Bhattacharya
All quotes →“your paper is worth the attention of other scientists.”
On the same topic: Biotech & medicine
More →“Novartis now expects to speak with the FDA about a potential accelerated approval of pelabresib before the end of the year, CEO Vas Narasimhan told investors on a call Tuesday.”
“The industry has gotten more consolidated. Prices are higher than ever. Access is worse than ever.”
“The rising costs are unsustainable for individuals, for businesses, and for the country. What kind of intervention is a different question.”